A critical gap in the field of transplantation tolerance is the lack of available tests or biomarkers to indicate when a patient has become partially or totally tolerant to their graft. Here, Hernandez-Fuentes and Lechler discuss advances in the development of biomarkers of transplantation tolerance and describe the potential utility of such biomarkers for the modification of protocols in clinical practice.
- Maria P. Hernandez-Fuentes
- Robert I. Lechler